NewsRx

Search our medical news database

Bentley Pharmaceuticals, Inc.

Pharmaceutical firm retains investor relations counsel

Published in Lab Business Week, January 16th, 2005

Bentley Pharmaceuticals, Inc., (BNT) announced that it has retained New York-based Porter, Le Vay & Rose (PLR) as its investor relations counsel.

Bentley's business generates revenues through manufacturing and marketing of branded pharmaceuticals, generic pharmaceuticals, licensing and supply collaborations with other pharmaceutical companies and export sales to customers, primarily in Europe.

It also receives royalties from Auxilium Pharmaceuticals, Inc., (AUXL), based upon sales of its Testim testosterone gel, and it has recently signed a collaboration agreement with Perrigo Co. (PRGO) for the introduction of products into the United States.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook